Live Breaking News & Updates on Prnewswire Delix Therapeutics The Company

Stay updated with breaking news from Prnewswire delix therapeutics the company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Delix Therapeutics Retains KCSA Strategic Communications


Delix Therapeutics Retains KCSA Strategic Communications
KCSA to provide integrated public and investor relations counsel
News provided by
Share this article
Share this article
BOSTON, May 19, 2021 /PRNewswire/ Delix Therapeutics (the Company ), a preclinical biotech company developing novel disease-modifying therapeutics for serious psychiatric and neurological conditions, today announced that it has retained KCSA Strategic Communications, a leading integrated communications firm, as its agency of record (AOR).
KCSA will implement a comprehensive strategic communications program that aims to educate the investment, biopharmaceutical, and patient advocacy communities on Delix s innovative research and mission. KCSA will assist Delix in advancing the understanding of how non-hallucinogenic analogs of psychedelic compounds can be developed into safe, FDA-approved, take-at-home medicines for the treatment of central nervous system-related conditions. ....

United States , Lewis Goldberg , Mark Rus , Davide Olson , Department Of Chemistry At University California , Strategic Communications , Prnewswire Delix Therapeutics The Company , Chief Scientific Officer Professor David , Chief Executive Officer Mark , Managing Partner , Professor David , Chief Scientific Officer , Assistant Professor , Delix Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , லெவிஸ் கோல்ட்பர்க் , குறி ரஸ் , டேவிட் ஓல்சன் , மூலோபாய தகவல்தொடர்புகள் , தலைமை நிர்வாகி அதிகாரி குறி , நிர்வகித்தல் கூட்டாளர் , ப்ரொஃபெஸர் டேவிட் , தலைமை அறிவியல் அதிகாரி , உதவியாளர் ப்ரொஃபெஸர் ,